GlassScriptPhysician profile
Joseph C Cambio
NPI 1346245305
$4,024.70
in general payments reported to CMS, 2019-2025
33 companies · $764 in 2025
The $764 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $223 · 2021: $374 · 2022: $517 · 2023: $774 · 2024: $1,054 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,121 · Travel and Lodging: $436 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,121.38 |
| Travel and Lodging | $436.23 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $799.63 | 2021-2024 | Urolift |
| Axonics, INC. | $685.77 | 2021-2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $355.13 | 2019-2025 | Xtandi, Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $220.76 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $205.73 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $188.18 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $167.24 | 2025 | Provenge |
| Blue Earth Diagnostics | $144.63 | 2019 | |
| Abbvie INC. | $135.81 | 2025 | |
| Neotract INC. | $107.12 | 2019-2020 | |
| Antares Pharma, INC. | $106.91 | 2021-2025 | Xyosted |
| Endo USA, INC. | $78.10 | 2024-2025 | Aveed, Xiaflex |
| Urovant Sciences INC | $71.49 | 2021-2022 | |
| Coloplast Corp | $68.61 | 2020-2025 | |
| Janssen Biotech, INC. | $68.61 | 2023 | Erleada |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $65.54 | 2021-2025 | Imfinzi |
| Innovation Technologies INC | $62.46 | 2024 | Irrisept |
| Olympus America INC. | $54.68 | 2023-2024 | Sureglide, Olympus, Soltive |
| Profound Medical Corp. | $51.26 | 2025 | Tulsa-Pro |
| Endo Pharmaceuticals INC. | $47.27 | 2023 | Aveed, Xiaflex |
| Histosonics, INC. | $47.08 | 2025 | |
| Medtronic, INC. | $37.90 | 2021-2024 | Interstim |
| Caris Mpi, INC. | $32.09 | 2025 | Mi Cancer Seek |
| Myovant Sciences INC. | $31.24 | 2021 | |
| Laborie Medical Technologies Corp. | $29.46 | 2020 | |
| Procept Biorobotics Corporation | $28.06 | 2024 | Aquabeam System |
| Novo Nordisk INC | $26.68 | 2024 | |
| Agiliti Surgical, INC. | $22.90 | 2023 | Trinity, Sonablate |
| Merck Sharp & Dohme LLC | $21.44 | 2024 | Keytruda |
| Palette Life Sciences, INC. | $19.20 | 2023 | |
| Aytu Biopharma, INC. | $14.82 | 2019 | |
| Valencia Technologies Corporation | $14.50 | 2025 | Ecoin Device Kit |
| Allergan, INC. | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cambio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.